Inflammation-Linked Muscle Atrophy in Limb Girdle Muscular Dystrophy R1 (LGMDR1): Insights into Disease Mechanisms

Area of Science:

• Molecular Biology
• Biochemistry
• Genetics

Background:

• Muscle atrophy is a key symptom in Limb Girdle Muscular Dystrophy R1 (LGMDR1).
• The ubiquitin-proteasome system (UPS) degrades muscle proteins, and inflammation may exacerbate this process in LGMDR1.
• The precise role of inflammation in LGMDR1 muscle wasting requires further investigation.

Purpose of the Study:

• To investigate the role of inflammation in muscle atrophy observed in LGMDR1 patients.
• To explore the relationship between inflammatory cytokines and the ubiquitin-proteasome system (UPS) in LGMDR1.

Main Methods:

• Analyzed muscle biopsies from six LGMDR1 patients for atrophy markers (MuRF1, Atrogin-1) and inflammatory cytokines (TNF-α, IL-1β, IL-6) using qRT-PCR and Western blotting.
• Measured cytokine levels in serum via ELISA.
• Assessed gene expression of NFκB, FOXO1, and FOXO3 in muscle tissue.

Main Results:

• Elevated TNF-α levels correlated with increased UPS activity in LGMDR1 patients.
• NFκB, FOXO1, MuRF1, and Atrogin-1 expression were upregulated, indicating enhanced UPS activation.
• These findings link inflammation to the molecular pathways of muscle wasting.

Conclusions:

• Increased TNF-α expression is linked to muscle wasting in LGMDR1 by activating UPS pathway mediators.
• The study identifies MuRF1 and Atrogin-1 as key ubiquitin ligases involved in this process.
• Targeting TNF-α signaling presents a potential therapeutic strategy for LGMDR1-associated muscle atrophy.